Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists

Digestion

Volumn 60, Issue SUPPL. 1, 1999, Pages 69-74

  Grendell, James H ^b   Niederau, Claus ^a  

^a St Josef Hospital Oberhausen   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Caerulein; Cholecystokinin; Cholecystokinin receptor; Pancreatic secretion; Pancreatitis

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT;

ACUTE PANCREATITIS; ANIMAL MODEL; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 0344197067     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051458     Document Type: Conference Paper

References (63)

1. Evander A, Ihse I, Lundquist I: Influence of hormonal stimulation on acute experimental pancreatitis in the rat. Eur Surg Res 1981;13: 257-268.
2. Evander A, Lundquist I, Ihse I: Influence of gastrointestinal hormones on the course of acute experimental pancreatitis. Hepatogastroenterology 1982;29:161-166.
3. Niederau C, Liddle RA, Ferrell LD, Grendell JH: Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 1986;78: 1056-1063.
4. Sarraf CE, Watanapa P, Emons VE, Williamson RC, Alison MR: Severe subcellular damage in the rat exocrine pancreas after pancreatobiliary diversion. Pancreas 1993;8:338-345.
5. Samuel I, Toriumi Y, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ: Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats. Am J Surg 1995;169:391-399.
6. Murayama KM, Drew JB, Yokoo H, Joehl RJ: Bile exclusion from the gut exacerbates acute pancreatitis caused by pancreatic duct obstruction in rats. Pancreas 1991;6:175-181.
7. Gomez G, Townsend CM Jr, Green DW, Rajaraman S, Uchida T, Greeley GH Jr, Soloway RD, Thompson JC: Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. J Clin Invest 1990;86:323-331.
8. Niederau C, Borchard F, Lüthen R, Niederau M: Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade. Hepatogastroenterology 1996;43:1442-1453.
9. Murayama KM, Samuel I, Toriumi Y, Solomon TE, Turkelson CM, Joehl RJ: Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. J Surg Res 1993;54: 126-131.
10. Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ: Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic obstruction with and without bile duct obstruction. J Surg Res 1993;54:132-135.
11. Takacs T, Czako L, Jarmay K, Hegyi P, Pozsar J, Marosi E, Pap A, Lonovics J: Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats. Acta Med Hung 1994;50: 117-130.
12. Green GM, Lyman RL: Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats. Proc Soc Exp Biol Med 1972;140:6-12.
13. Green GM, Olds BA, Matthews G, Louis DS: Protein, as a regulator of pancreatic enzyme secretion in the rat. Proc Soc Exp Biol Med 1973;142:1162-1167.
14. Fölsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W: Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 1987;92:449-458.
15. Gomez G, Upp JR, Lluis F, et al: Regulation of the release of cholecystokinin by bile salts in dogs and humans. Gastroenterology 1988;94: 1036.
16. Lu L, Louie D, Owyang C: A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion. Am J Physiol 1989; 256:G430-G435.
17. Nakamura R, Miyasaka K, Funakoshi A, Kitani K: Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats. Proc Soc Exp Biol Med 1989;192:182.
18. Niederau C, Niederau M: Effects of CCK-receptor antagonist on pancreatic feedback regulation; in Beger HG, Büchler M, Ditschuneit H, Malfertheiner P (eds): Chronic Pancreatitis. Berlin, Springer, 1990, pp 186-197.
19. Shirohara H, Otsuki M: Plasma cholecystokinin levels in acute pancreatitis. Pancreas 1997; 14:249-254.
20. Hahne WF, Jensen RT, Lemp GF, Gardener JD: Proglumide and benzotript: Members of a different class of cholecystokinin receptor antagonists. Proc Natl Acad Sci USA 1981;78: 6304-6310.
21. Niederau C, Niederau M, Williams JA, Grendell JH: New proglumide analogue CCK-receptor antagonists: Very potent and selective for peripheral tissues. Am J Physiol 1986;251: G856-G860.
22. Makovec F, Chiste R, Bani M, Pacini MA, Setnikar I, Rovati LA: New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittel-Forsch 1985;35:1048-1051.
23. Niederau M, Niederau C, Strohmeyer G, Grendell JH: Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Am J Physiol 1989;256:G1-G8.
24. Chang RSL, Monaghan RL, Birnbaum J, Stapley EO, Goetz MA, Albers-Schonberg G, Patchett AA, Licsch JM, Hensens OD, Springer JP: A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus aliaceus, Science 1985;230: 177-179.
25. Chang RSL, Lotti VJ: Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin receptor antagonist. Proc Natl Acad Sci USA 1986;83:4923-4926.
26. Lotti VJ, Pendeleton G, Gould RJ, Hanson HM, Chang RSL, Clineschmidt BV: In vivo pharmacology of L-364,718, a new potent non-peptide peripheral cholecystokinin receptor antagonist. J Pharmacol Exp Ther 1987;241:103-109.
27. Niederau C, Liddle RA, Williams JA, Grendell JH: Pancreatic growth: Interaction of exogenous cholecystokinin. a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut 1987;28:63-69.
28. Niederau C, Heintges T, Rovati L, Strohmeyer G: Effects of loxiglumide on gallbladder emptying in healthy volunteers. Gastroenterology 1989;97:1331-1336.
29. Niederau C, Karaus M: Effects of agonists and antagonists of cholecystokinin on contractile and myoelectric activity of isolated muscle of colon and ileum in the dog and guinea pig. J Gastrointest Motil 1990;2:160-175.
30. Setnikar I, Bani M, Cereda R, Chiste R, Makovec F, Pacini MA, Revel L, Rovati LC, Rovati LA: Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneimittel-Forsch 1987;6:703-707.
31. Chang TM, Chey WY: Radioimmunoassay of cholecystokinin. Dig Dis Sci 1983;28:456-468.
32. Liddle RA, Goldfine ID, Williams JA: Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhihitor, and alcohol. Gastroenterology 1984;87:542-549.
33. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA: Cholecystokinin bioactivity in human plasma: Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985;75:1140-1142.
34. Jansen JBMJ, Lamers BHHW: Radioimmunoassay of cholecystokinin in human tissue and plasma, Clim Chim Acta 1983;33:2197-2205.
35. Grendell JH: Experimental pancreatitis: in Adler G, Beglinger C (eds): CCK Antagonists in Gastroenterology. Berlin, Springer, 1991, pp 197-202.
36. Letko G, Nosofsky T, Lessel W, Siech M: Transition of rat pancreatic juice edema into acute pancreatitis by single ethanol administration. Pathol Res Pract 1991;187:247-250.
37. Siech M, Heinrich P, Letko G: Development of acute pancreatitis in rats after single ethanol administration and induction of a pancreatic juice edema. Int J Pancreatol 1991;8:169-175.
38. Foitzik T, Lewandrowski KB, Fernandez-del Castillo C, Rattner DW, Klar E, Warshaw AL: Exocrine hyperstimulation but not pancreatic duct obstruction increases the susceptibility to alcohol-related pancreatic injury. Arch Surg 1994;129:1081-1085.
39. Hirano T, Manabe T: A new experimental model for gallstone pancreatitis: Short-termed pancreatico-biliary duct obstruction and exocrine stimulation with systemic hypotension in rats, Nippon Geka Hokan 1993;62:3-15.
40. Hirano T, Manabe T: A possible mechanism for gallstone pancreatitis: Repeated short-term pancreaticobiliary duct obstruction with exocrine stimulation in rats. Proc Soc Exp Biol Med 1993;202:246-252.
41. Zhou W, Shen F, Miller JE, Han Q, Olson MS: Evidence for altered cellular calcium in the pathogenetic mechanism of acute pancreatitis in rats. J Surg Res 1996;60:147-155.
42. Ha SS, Satake K, Hiura A: Role of endogenous and exogenous cholecystokinin in experimental acute pancreatitis induced in rats by the duodenal loop technique. J Gastroenterol 1996;31:404-413.
43. Niederau C, Ferrell LD, Grendell JH: Caerulein-induced acute necrotizing pancreatitis in mice: Protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985;88: 1192-1204.
44. Garcia-Montero AC, Manos MA, Rodriguez AI, De Dios I: Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis. Pancreas 1994;9:309-315.
45. Makovec F, Bani M, Cereda R, Chiste R, Revel L, Rovati LC, Setnikar I, Rovati LA: Protective effect of Cr1409 (cholecystokinin antagonist ) on experimental pancreatitis in rats and mice. Peptides 1986;7:1159-1164.
46. Otsuki M, Tani S, Okabayashi Y, Nakamura T, Fujii M, Fujisawa T, Baba S, Itoh H: Effect of a new cholecystokinin receptor antagonist CR1392 on caerulein-induced acute pancreatitis in rats. Pancreas 1989;4:237-243.
47. Murayama KM, Drew JB, Nahrwold DL, Joehl RJ: Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in caerulein-induced acute pancreatitis. Pancreas 1990;5:439-444.
48. Kobayashi M, Shinagawa K, Sugiura M, Nagasawa T, Akahane M, Ahjisawa Y: Effect of (CSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice. Nippon Yakurigaku Zasshi 1996;107: 183-195.
49. Modlin IM, Bilchik AJ, Zucker KA, Adrian TE, Susman J, Graham SM: Cholecystokinin augmentation of 'surgical' pancreatitis: Benefits of receptor blockade. Arch Surg 1989;124: 574-578.
50. Larsen F, Schlarmann D, Andrus CC, Kaminski DL: The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum. Pancreas 1991;6:291-297.
51. Wisner JR Jr, Renner IG: Asperlicin, a non-peptidal cholecystokinin antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats. Pancreas 1988;3:174-179.
52. Tani S, Itoh H, Koide M, Okabayashi Y, Otsuki M: Involvement of endogenous cholecystokinin in the development of acute pancreatitis induced by close duodenal loop. Pancreas 1993;8:109-115.
53. Nordback ICH, Clemens JA, Cameron JK: The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation. Surgery 1991;109:301-306.
54. Silverman M, Ilardi C, Bank S, Kranz V, Lendvai S: Effects of the cholecystokinin antagonist L-364,718 on experimental pancreatitis in mice. Gastroenterology 1989;96:186-192.
55. Oshio G, Saluja A, Leli U, Segupta A, Steel ML: Failure of potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice. Pancreas 1989;4:739-743.
56. Tani S, Okabayashi Y, Nakamura T, Fujii M, Itoh H, Otsuki M: Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models. Pancreas 1990;5:284-290.
57. Leonhardt U, Seidensticker F, Fussek M, Stockmann F, Creutzfeldt W: Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis. Int J Pancreatol 1991;10:73-80.
58. Bilchik AJ, Zucker KA, Adrian TE, Modlin IM: Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist. Arch Surg 1990;125:1546-1549.
59. Kosidlo S, Rydzewska G, Gabryelewicz A: The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-amiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats. Mater Med Pol 1992;24: 223-226.
60. Taniguchi H, Yomota E, Kume E, Shikano T, Endo T, Nagasaki M: Effect of T-0632, acholecystokinin A receptor antagonist, on experimental acute pancreatitis. Jpn J Pharmacol 1997;73:105-112.
61. Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K, Fujimora Y, Got T, Kono A: Disrupted cholecystokinin type-A-receptor gene in OLETF rats. Gene 1997;197:169-175.
62. Funakoshi A, Miyasaka K, Jimi A, Kawanai T, Takata Y, Kono A: Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats). Biochem Biophys Res Commun 1994;199:482-488.
63. Tachibana I, Shirohara H, Czako L, Akiyama T, Nakano S, Watanabe N, Hirohata Y, Otsuki M: Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats. Pancreas 1997;14:113-121.